Live Breaking News & Updates on Rugmaker

Stay informed with the latest breaking news from Rugmaker on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rugmaker and stay connected to the pulse of your community

US sues Regeneron Pharmaceuticals

US sues Regeneron Pharmaceuticals
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Brian-boynton , Justice-department , Regeneron-pharmaceuticals , New-york-based , Deputy-attorney-general-brian-boynton , False-claims-act , Us , Awsuit , Egeneron-pharmaceuticals , Edicare , Ylea , Njection-therapy

US accuses Regeneron of fraudulent price reporting for eye drug

BOSTON (Reuters) -The U.S. Justice Department on Wednesday accused Regeneron Pharmaceuticals of manipulating Medicare's drug-pricing process by inflating the average sales price for its expensive macular degeneration drug Eylea. The department, in a complaint filed in federal court in Boston, alleged the drugmaker failed for years to report how it paid hundreds of millions of dollars to subsidize Eylea purchases by reimbursing drug distributors for credit-card processing fees. Those payments wer

Massachusetts , United-states , Boston , Leslie-adler , Dan-whitcomb , Nate-raymond , Drug-administration , Justice-department , Us-justice-department-on , Us-attorney-office , Regeneron-pharmaceuticals , Reuters

J&J to acquire heart devicemaker for $13B

J&J to acquire heart devicemaker for $13B
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Johnson , Abiomed , Shockwave-medical , Wall-street , Definitive-agreement , Ohnson , Efinitive , Eached , Ohnson-amp-johnson , Ardiovascular , Cquire

Amgen sues Colorado for potential price limit on arthritis drug

Amgen sues Colorado for potential price limit on arthritis drug
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Colorado , United-states , Amgen-enbrel , Amgen , Prescription-drug-affordability-board , Affordability , Rescription , Rugmaker , Iled , Onths , Awsuit ,

Alembic Pharma drops 2% on USFDA 4 observations for Gujarat facility

The US drug regulator had inspected Alembic Pharma's oncology formulations (injectable and oral solid) unit at Panelav in Gujarat from February 28 to March 8

India , Alembic-pharmaceuticals , Alembic-pharmaceuticals-md-shaunak-amin , Drug-administration , Alembic-pharma , Uzzing-stocks , Sfda , Lembic-pharma-usfda , Rugmaker ,

Novo Nordisk working with global authorities to take down fake Ozempic: Reuters

Novo Nordisk's CEO addresses growing concern over counterfeit Ozempic, found in 16 countries and linked to adverse events.

Egypt , Iraq , Jordan , World-health-organization , Al-qahirah , Ireland , Switzerland , Germany , Turkey , Russia , Nigeria , Lebanon

Sinopharm offers to take Hong Kong-listed China-TCM private in nearly US$3 billion deal

A consortium led by state-owned Sinopharm has revived a take-private bid for China-TCM, the Hong-Kong-listed drug maker said on Wednesday, valuing it at US$2.96 billion.

Hong-kong , China , Chinese , Xinyao-wang , Hong-kong-listed , Haier-electronic , Tcm , Raditional-chinese-medicine , Inopharm , Hina-traditional-chinese-medicine-holdings , Hina-tcm

Discontinued asthma drug stirs frustrations

Discontinued asthma drug stirs frustrations
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Cnn , Gsk , Iscontinued , Rand-name , Sthma-drug , Lovent , Eneric-solution , Rugmaker , Luticasone , Ayers , Lternative-therapies

Newly acquired Novo Nordisk plant struggles to meet quality standards, FDA finds

Newly acquired Novo Nordisk plant struggles to meet quality standards, FDA finds
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Italy , Belgium , Novo-nordisk , Bloomberg , Information-act , Meta-keywords-fda , Afety , Uality-issues , Anufacturing-sites , Ovo-nordisk , Urchase

Lilly sees 2024 profit above estimates on strong demand for weight-loss drug

(Reuters) -Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for its recently approved weight-loss drug, and said the treatment helped reduce symptoms of a common, difficult to treat fatty liver disease in a mid-stage trial. Shares of the Indianapolis-based drugmaker jumped nearly 5% in premarket trading after gaining about 11% in January, making Lilly the eighth largest company in the U.S. by market capitalization and most valuable healthcare company.

New-york , United-states , Bengaluru , Karnataka , India , Bhanvi-satija , Patrick-wingrove , Leroy-leo , Arun-koyyur , Eli-lilly , Novo-nordisk , Reuters